Dual Thrombolytic Therapy With Mutant Prourokinase and Small Bolus Alteplase for Ischemic Stroke
This randomized clinical trial of individuals with ischemic stroke assesses the safety and efficacy of treatment with a dual plasminogen activator vs usual treatment with intravenous alteplase.
Source: JAMA Neurology - Category: Neurology Source Type: research
More News: Activase | Brain | Clinical Trials | Ischemic Stroke | Neurology | Stroke | Thrombolytic Therapy | Thrombosis